Mirum Pharmaceuticals, Inc. announced the appointment of Doug Sheehy, JD, as its new chief legal officer. Mr. Sheehy brings nearly two decades of experience leading global legal and compliance operations for biopharmaceutical companies.
Prior to joining Mirum, Mr. Sheehy served as chief legal officer and secretary at Sonoma Biotherapeutics, Inc., and previously as general counsel and secretary for Aimmune Therapeutics, Inc. His extensive background includes guiding companies through transformative growth and acquisitions.
This appointment strengthens Mirum's leadership team as the company continues to expand its commercial business and advance its rare disease pipeline. Mr. Sheehy's expertise is expected to be instrumental in navigating the complex legal and regulatory environment of the biopharmaceutical industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.